Andrew Cope
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- Rheumatoid Arthritis Research and Therapies 2
- Systemic Lupus Erythematosus Research 1
-
- Immunodeficiency and Autoimmune Disorders 1
- Co-authors
- Sophie Papa (2 shared papers)Beth Russell (1 shared paper)Charlotte Moss (1 shared paper)Gincy George (1 shared paper)Aida Santaolalla (1 shared paper)Mieke Van Hemelrijck (1 shared paper)Mark T. Drayson (1 shared paper)Alex Richter (1 shared paper)
- Journals
- Nature Communications (1 paper)Annals of the Rheumatic Diseases (1 paper)RMD Open (1 paper)ecancermedicalscience (1 paper)
- Partner nations
- United KingdomBelgiumFrance
In The Last Decade
Andrew Cope
4 papers receiving 356 citations
Peers
Comparison fields: 5 of 68
- Infectious Diseases 239
- Neurology 135
- Obstetrics and Gynecology 28
- Oncology 77
- Immunology 47
Countries citing papers authored by Andrew Cope
This map shows the geographic impact of Andrew Cope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Cope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Cope more than expected).
Fields of papers citing papers by Andrew Cope
This network shows the impact of papers produced by Andrew Cope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Cope. The network helps show where Andrew Cope may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Cope, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 323 | |
| 2 | 2022 | 41 | |
| 3 | 2024 | 1 | |
| 4 | 2022 | 1 |
About Andrew Cope
Andrew Cope is a scholar working on Rheumatology, Immunology, Infectious Diseases, Molecular Biology and Rehabilitation, having authored 4 papers that have together received 366 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (2 papers), CAR-T cell therapy research (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Systemic Lupus Erythematosus Research (1 paper), Musculoskeletal Disorders and Rehabilitation (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (239 citations), Neurology (135 citations), Obstetrics and Gynecology (28 citations), Oncology (77 citations) and Immunology (47 citations). Andrew Cope has collaborated with scholars based in United Kingdom, Belgium and France. Frequent co-authors include Sophie Papa, Beth Russell, Charlotte Moss, Gincy George, Aida Santaolalla, Mieke Van Hemelrijck, Mark T. Drayson, Alex Richter, Zena Willsmore and Gary Middleton. Their work appears in journals such as Nature Communications, Annals of the Rheumatic Diseases, RMD Open and ecancermedicalscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.